Osteoporosis Foundation of New Mexico Santa Fe Bone Symposium 2024

1. Overview
The Osteoporosis Foundation of New Mexico Santa Fe Bone Symposium 2024 provides a comprehensive clinical review of the latest advancements in the diagnosis, treatment, and management of osteoporosis and metabolic bone diseases. The program highlights emerging therapeutics, the effects of hormones on bone health, and practical strategies for optimizing bone health in complex patient populations.
Course Date: 2024
2. Learning Objectives

Evaluate the efficacy and clinical application of new and emerging therapeutics for osteoporosis and rare bone diseases.

Implement evidence-based strategies for managing patients discontinuing denosumab and treating osteoporosis in the very elderly.

Assess the relationship between osteoporosis medications and cardiovascular diseases to ensure safe prescribing practices.

Analyze the role of hormones, including estrogen and testosterone, in the management and prevention of bone loss.

Formulate protocols for optimizing bone health prior to orthopedic surgery and effectively utilizing osteoanabolic agents.

3. Target Audience

Best for endocrinologists, rheumatologists, and primary care physicians who want updates on osteoporosis management and novel bone therapeutics.

4. Topics
Topics (13 Lectures):

01 Oral Abstracts Presentations by Endocrinology Fellows

02 Dr. Bobo Tanner, Winner of the Paul D. Miller Award

03 Osteoporosis Treatment in the Very Old

04 Osteoporosis Drugs and Cardiovascular Diseases

05 Case Discussions

06 Management of Patients Discontinuing Denosumab

07 Open Microphone Panel Discussion

08 Estrogen in the Management of Osteoporosis

09 Effects of Testosterone on Bone – Its Role in the Management of Osteoporosis

10 Treat-to-Target for Osteoporosis

11 New and Emerging Therapeutics for Rare Bone Diseases

12 Update on Clinical Aspects and Uses of Osteoanabolic Agents

13 Bone Health Optimization for Orthopedic Surgery